JSPR Penghasilan resik perusahaan Jasper Bio

Roland Martel's team is demonstrating flawless precision in conducting clinical trials, as confirmed by the GURU.Markets platform daily chart: the company's real profit is growing, and -0.03 is recording a new level mark. This creates a foundation for implementing safe bone marrow transplant preparation standards, turning the targeted therapy of Jasper Therapeutics (JSPR) into an indispensable element of modern hematology.

JSPR jaspertherapeutics.com: Penghasilan resik ing interval 04.07.2022 - 31.10.2026

Rincian metrik keuangan lan pasar jaspertherapeutics.com (JSPR)

- rega saham lan konsensus proyeksi valuasi:

Bagan rega Jasper Therapeutics, Inc.|JSPR - Bagan rega target

- data kapitalisasi pasar:

Nilai pasar JSPR|JSPR - Nilai Perusahaan

- data ekuitas miturut neraca:

Nilai Buku Siji Saham Jasper Therapeutics|JSPR - Aset Bersih Perusahaan|Koefisien Nilai Pasar marang Nilai Buku jaspertherapeutics.com|JSPR - Gunggung Aset Perusahaan

- indikator beban utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi Jasper Therapeutics|JSPR - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Jasper Therapeutics, Inc.|JSPR - Gunggung utang perusahaan|Utang-utang marang nilai buku JSPR|JSPR - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Jasper Therapeutics|Likuiditas cepet jaspertherapeutics.com

- data bathi bisnis lan rasio investasi:

JSPR - Penghasilan resik

Pambiji fundamental:JSPR Jasper Bio

Produk sing diprodhuksi Jasper Therapeutics Inc

This indicator reflects the real equity value of operating income, adjusted for accounting pauses, allowing investors to objectively assess capital generation efficiency relative to debt obligations. The stable net income level of Jasper Therapeutics (JSPR) amid neutral US geopolitics confirms the predictability of its cash flows, turning this metric into a reliable marker of fundamental business resilience in the development of biologics.

Pesaing utama